The medicines used for MS are typically divided into two categories: disease-modifying therapies (DMTs) and symptom-managing therapies. DMTs are used to reduce the rate of disability progression in patients with relapsing forms of MS. These medications work by preventing or reducing the impact of inflammation, which is responsible for a lot of the disability in MS. Common DMTs include interferon beta, glatiramer acetate, and natalizumab.
Symptom-managing therapies are used to treat the more immediate symptoms of MS, such as muscle spasticity, pain, fatigue and cognitive dysfunction. These therapies are usually in the form of medications, although some may be delivered through other means, such as injections or infusions. Common symptom-managing medicines include steroids, muscle relaxants, immune suppressants, stimulants, and antidepressants.
The positive benefits of these MS medicines go beyond alleviating individual symptoms. In some cases, they are able to actually reduce or halt the progression of the disease, allowing patients to maintain a relatively normal lifestyle. Furthermore, they can reduce the risk of disability progression and reduce the severity of symptoms, allowing patients to enjoy a better quality of life.
Studies have also found that disease-modifying therapies can help slow disease progression by up to 40%, while symptom-managing therapies can reduce disability progression by up to 20%.
These medicines have also been found to help reduce the risk of relapse in patients with relapsing forms of MS. In addition, they can lead to a quicker recovery after a relapse, meaning that patients can be back on their feet sooner rather than later.
Overall, the positive effects of MS medicines should not be underestimated. By controlling symptoms and preventing disease progression, these drugs can have a life-changing impact on the lives of those living with MS.
Article Created by A.I.